Abstract
Background & Objectives While exposure to fine particulate matter air pollution (PM2.5) is known to cause adverse health effects, its impact on postoperative outcomes in US adults remains understudied. Perioperative exposure to PM2.5 may induce inflammation that insidiously interacts with the systemic inflammatory response after surgery, leading to higher postoperative complications.
Methods We conducted a single center, retrospective cohort study using data from 64,313 surgical patients living along Utah’s Wasatch Front and undergoing elective surgical procedures at a single academic medical center from 2016-2018. Patients’ addresses were geocoded and linked to daily Census-tract level PM2.5 estimates preoperatively. We hypothesized that elevated PM2.5 concentrations in the seven days prior to surgery would be associated with an increase in a bundle of major postoperative complications. A hierarchical Bayesians regression model was fit adjusting for age, sex, season, neighborhood disadvantage, and the Elixhauser index of comorbidities.
Results Postoperative complications increased in a dose-dependent manner with higher concentrations of PM2.5 exposure, with a relative increase of 7% in the odds of complications for every 10ug/m3 increase in the highest single-day 24-hr PM2.5 exposure during the 7 days prior to surgery. The association persisted after controlling for comorbidities and potential confounders; our inferences were robust to modeling choices and sensitivity analysis.
Discussion & Conclusion In this large Utah cohort, exposure to elevated PM2.5 concentrations in the week before surgery was associated with increased postoperative complications in a dose-dependent manner, suggesting a potential impact of air pollution on surgical outcomes. These findings merit replication in larger datasets to identify populations at risk and to define the interaction and impact of different pollutants. PM2.5 exposure is a potential perioperative risk factor and, given the unmitigated air pollution in urban areas, a global health concern.
Competing Interest Statement
Ben Goodrich and Jonah Gabry are both member-managers of GG Statistics, LLC.
Funding Statement
This study was funded from an intramural University of Utah Wilkes Center for Climate Science and Policy seed grant [to JFP and NW] as well as partially supported by the National Institute of Health National Institute of Environmental Health Sciences and National Cancer Institute (NIH grant 5R01ES029528-05 [to MS], 5R37CA276365-02 [to NW]). Further funding was from the National Science Foundation (NSF grant 2051246 [BG] and 2153019[BG]). The funding sources were not involved in the study design, collection, analysis and interpretation of the data, in writing the report, or in the decision to submit the article for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the National Science Foundation, or the University of Utah Wilkes Center for Climate Science and Policy.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board of the University of Utah gave ethical approval of this work as Category 4, Exempt with IRB approval number 00142167.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
